MAXIMUS, Inc.

Day range

$62.24 – $63.86

Open

$63.03

Prev close

$63.38

Volume

159.95K

Market cap

$3.32B

Shares out

52.36M

P/E

8.95

P/S

0.63

P/B

1.91

P/FCF

7.66

ROE

21.3%

ROA

8.5%

Debt/Equity

0.94

Div yield

2.06%

As of Oct 22, 2026

• Investor communicationsOct 20, 2026

  On October 20, 2026, the Company announced, without accounting for the Acquisition, a preliminary ratio of debt, net of allowed cash, to consolidated EBITDA ... of 1.7x.

• Debt activityMay 28, 2026

  Maximus, Inc. entered into the Second Amendment to Amended and Restated Credit Agreement with JPMorgan Chase Bank, N.A., which amended the Amended and Restated Credit Agreement, dated as of May 30, 2024. The Amendment provides for new term B loans in an aggregate principal amount of $325,000,000 (the 'Tranche B-1 Term Loans') in the form of an increase to the existing term B loans.

• Shareholder meetingsMar 11, 2026

  At our Annual Meeting of Shareholders held on March 10, 2026, 50,864,001 shares, representing 93.2% of the outstanding common stock of Maximus, Inc. (the "Company") entitled to vote, were represented in person or by proxy. Our shareholders voted as follows: (a) To elect Anne K. Altman, Bruce L. Caswell, John J. Haley, Jan D. Madsen, Richard A. Montoni, Gayathri Rajan, Raymond B. Ruddy and Michael J. Warren as directors for one-year terms expiring at the 2027 Annual Meeting of Shareholders.

• Executive leadershipDec 18, 2025

  On December 15, 2025, Maximus, Inc. (the "Company") received notice from John T. Martinez, the Company's Chief Legal Officer and Corporate Secretary, of his intention to resign effective February 15, 2026. Mr. Martinez' resignation is solely due to his personal desire to pursue a new opportunity that is more closely aligned with his industry background and experience and not due to any disagreement with the Company on any matter relating to the Company's operations, policies, or practices.

• Shareholder returnsSep 10, 2025

  On September 8, 2025, the Board of Directors (the "Board") of Maximus, Inc. (the "Company") approved an increase to the Company's existing stock purchase program. The increased stock purchase program authorizes the Company to purchase up to an aggregate amount of $400 million of the Company's common stock, no par value ("Common Stock").

Days to cover

4.1

Short interest

3.41M

Avg volume

828.36K

As of Sep 30, 2026 · reported to FINRA twice monthly.

• Strategic Buyouts & Strong Cash Profile Aid VLTO Amid Stiff Rivalry
  neutralZacks Investment Research· Sep 1, 2026
• Maximus Ranked #7 on the Financial Times’ List of The Americas’ Fastest Growing Companies 2026
  positiveGlobeNewswire Inc.· Apr 3, 2026
• Maximus Announces First-Ever Topical Oxytocin Cream for Mood Enhancement and Sleep Support
  positiveGlobeNewswire Inc.· Nov 7, 2025
• Case Management Market to Reach USD 17.43 Billion by 2032, Driven by AI-Powered Workflow Automation | SNS Insider
  positiveGlobeNewswire Inc.· May 16, 2025
• 4 Stocks Trading Near 52-Week High That Can Climb Further
  Zacks Investment Research· Jun 28, 2024